Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

General

General

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Earnings
  • Equities
  • General
  • Guidance
  • Markets
  • Movers
  • News

What’s Going On With Harley-Davidson Shares After Q1 Results?

By Nabaparna Bhattacharya
April 25, 9:44 AM
Harley-Davidson shares dip despite beating Q1 earnings and revenue estimates, citing planned motorcycle shipment decrease.

HOG

Read More
1 minute read
  • Equities
  • General
  • Guidance
  • Movers
  • News

Why Beverage Company Keurig Dr Pepper’s Shares Are Surging Today

By Shivani Kumaresan
April 25, 9:26 AM
Keurig Dr Pepper impresses investors with a 3.5% year-on-year sales surge to $3.47 billion in Q1 FY24, outperforming analyst predictions. Notably, U.S. Refreshment Beverages lead the growth trajectory with a 4.3% rise to $2.1 billion.

KDP

Read More
2 minute read
  • Biotech
  • General
  • News

Aclarion’s Nociscan Solution To Play Key Role In LIFEHAB Trial Evaluating The Diagnosis And Treatment Of Chronic Low Back Pain

By Benzinga Newsdesk
April 25, 9:20 AM
LIFEHAB is a randomized controlled trial in Norway comparing lumbar interbody fusion surgery with multidisciplinary rehabilitationNorway is a single-payer national health insurance systemLIFEHAB is targeting enrollment

ACON

Read More
1 minute read
  • Earnings
  • Equities
  • General
  • Guidance
  • Markets
  • Movers
  • News

Brunswick Falls Over 2% After Q1 Earnings – Here’s Why

By Nabaparna Bhattacharya
April 25, 9:14 AM
Brunswick Corporation's shares decline over 2% premarket as Q1 earnings show sales dip and adjusted operating margin contraction.

BC

Read More
2 minute read
  • Equities
  • General
  • Markets
  • News

Nvidia Investments Shower Retail Investors With Massive Returns Despite Few Cloudy Days: Report

By Benzinga Neuro
April 25, 9:08 AM
Nvidia's transition from a gaming giant to an AI leader, especially during the early days of the pandemic, has been a significant driver of its stock's growth.

AAPL

Read More
2 minute read
  • Biotech
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News
  • Top Stories

AstraZeneca Posts Bumper Earnings On Strong Sales From Cancer Drugs, Sticks To Annual Guidance

By Vandana Singh
April 25, 9:03 AM
AstraZeneca reports Q1 sales of $12.68 billion, up 17% Y/Y. Despite missing adjusted EPADS, oncology sees a 26% surge, driven by Tagrisso and Imfinzi. Cardiovascular sales up 20%. R&D up 18%. Fiscal 2024 outlook: low double-digit revenue and EPS growth.

AZN

Read More
2 minute read
  • General
  • Global
  • News

US Faces Mounting Plastic Waste Challenge With Limited Recycling Solutions After China’s 2018 Import Ban: Report

By Benzinga Neuro
April 25, 8:51 AM
The United States is currently facing a significant plastic waste crisis, generating 40 million tons of plastic waste…

CVX

Read More
3 minute read
  • Biotech
  • General
  • News

Dario Publishes New Peer-Reviewed Study That Deepens The Body Of Evidence That Managing Cardiometabolic Conditions In One Integrated Platform Improves Clinical Outcomes

By Benzinga Newsdesk
April 25, 8:47 AM
Quasi-randomized study demonstrates the value of Dario's integrated approach to provide one solution for members to manage diabetes, pre-diabetes, blood pressure, weight and taking a GLP-1NEW YORK, April 25, 2024

DRIO

Read More
3 minute read
  • Biotech
  • General
  • News

Bausch + Lomb Announces Results From A Clinical Study Of A Novel Daily Nutritional Supplement For Dry Eyes, All Primary Endpoints Achieved

By Benzinga Newsdesk
April 25, 8:43 AM
Novel Supplement Shown to Address Signs and Symptoms of Dry Eyes, All Primary Endpoints AchievedBausch + Lomb Corporation (TSX:BLCO), a leading global eye health company dedicated to helping people see better to live

BLCO

Read More
3 minute read
  • Biotech
  • General
  • Global
  • News

Apollomics Announces Approval Of Vebreltinib In China As A First-In-Class Treatment For Gliomas With MET Fusion Gene

By Benzinga Newsdesk
April 25, 8:42 AM
Apollomics' partner in China, Avistone, received approval from National Medical Products Administration of China to expand the use of vebreltinib to the treatment of gliomas with PTPRZ1-MET fusion gene Approval

APLM

Posts pagination

Previous 1 … 165 166 167 … 2,367 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service